PT3522904T - Composição líquida para utilização no tratamento de refluxo gastroesofágico - Google Patents

Composição líquida para utilização no tratamento de refluxo gastroesofágico

Info

Publication number
PT3522904T
PT3522904T PT177971835T PT17797183T PT3522904T PT 3522904 T PT3522904 T PT 3522904T PT 177971835 T PT177971835 T PT 177971835T PT 17797183 T PT17797183 T PT 17797183T PT 3522904 T PT3522904 T PT 3522904T
Authority
PT
Portugal
Prior art keywords
treatment
liquid composition
gastroesophageal reflux
gastroesophageal
reflux
Prior art date
Application number
PT177971835T
Other languages
English (en)
Original Assignee
Sofar Swiss Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sofar Swiss Sa filed Critical Sofar Swiss Sa
Publication of PT3522904T publication Critical patent/PT3522904T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Insects & Arthropods (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Husbandry (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PT177971835T 2016-10-10 2017-10-10 Composição líquida para utilização no tratamento de refluxo gastroesofágico PT3522904T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102016000101413A IT201600101413A1 (it) 2016-10-10 2016-10-10 Composizione liquida per uso nel trattamento del reflusso gastroesofageo

Publications (1)

Publication Number Publication Date
PT3522904T true PT3522904T (pt) 2021-12-13

Family

ID=57960706

Family Applications (1)

Application Number Title Priority Date Filing Date
PT177971835T PT3522904T (pt) 2016-10-10 2017-10-10 Composição líquida para utilização no tratamento de refluxo gastroesofágico

Country Status (9)

Country Link
US (2) US11337992B2 (pt)
EP (1) EP3522904B1 (pt)
DK (1) DK3522904T3 (pt)
ES (1) ES2900565T3 (pt)
HU (1) HUE057257T2 (pt)
IT (1) IT201600101413A1 (pt)
PL (1) PL3522904T3 (pt)
PT (1) PT3522904T (pt)
WO (1) WO2018069832A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201600101413A1 (it) 2016-10-10 2018-04-10 Sofar Swiss S A Composizione liquida per uso nel trattamento del reflusso gastroesofageo
IT201800004332A1 (it) * 2018-04-09 2019-10-09 Composizione liquida per uso nel trattamento della mucosa del tratto oro-faringo-laringo-esofageo
IT201900008409A1 (it) * 2019-06-07 2020-12-07 Vivatis Pharma Gmbh Individuazione e selezione di un materiale di partenza vegetale di condroitina solfato e acido ialuronico vegetali, e trasformazione di tale materiale di partenza vegetale per l’ottenimento di ingredienti per utilizzo in alimenti, integratori, dispositivi medici o farmaci
IT202000022477A1 (it) * 2020-09-23 2022-03-23 Sofar Swiss Sa Composizioni comprendenti una condroitina vegetale o un suo analogo e loro uso nel trattamento disturbi della mucosa del tratto orale, faringo-laringeo e/o gastro-esofageo
IT202000022471A1 (it) * 2020-09-23 2022-03-23 Sofar Swiss Sa Composizioni comprendenti una condroitina vegetale o un suo analogo e loro uso nel trattamento disturbi della mucosa del tratto orale, faringo-laringeo e/o gastro-esofageo
IT202100021992A1 (it) * 2021-08-27 2023-02-27 Neilos S R L Composizione per la prevenzione e/o il trattamento delle patologie gastriche ed esofagee
IT202100021995A1 (it) * 2021-08-27 2023-02-27 Neilos S R L Composizione per la prevenzione e/o il trattamento delle patologie gastriche ed esofagee

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6147418A (ja) 1984-08-13 1986-03-07 Seikagaku Kogyo Co Ltd ヒアルロン酸含有胃粘膜保護剤
US5178878A (en) 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
US20040146993A1 (en) 2002-11-13 2004-07-29 Khare Anil B. Isolating chondroitin sulfate
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
AU2006270824B2 (en) * 2005-07-21 2010-09-02 Kabushiki Kaisha Yakult Honsha Novel bacterium belonging to the genus bifidobacterium and utilization of the same
US20090208588A1 (en) * 2008-02-19 2009-08-20 Roger Wayne Brown GERD carbohydrate compositions
WO2009138843A1 (en) * 2008-05-13 2009-11-19 Hertek S.A. Glycosaminoglycan oral use and compositions
DE102008034944B4 (de) * 2008-07-26 2017-03-16 Arivine Pharma Ag Mikroemulsion
TW201026700A (en) * 2008-12-22 2010-07-16 Hydra Biosciences Inc Compositions useful for treating disorders related to TRPA1
PT2435021E (pt) 2009-05-25 2013-09-30 Sofar Swiss Sa Utilização de uma combinação fixa de glicosaminoglicano e composição mastigável compreendendo a referida combinação fixa
CA2765033C (en) 2009-06-12 2020-07-14 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
US20110038945A1 (en) * 2009-08-13 2011-02-17 Gear Gavin M Orally ingestable medicament and method for treating a heartburn inducing event or an acid reflux episode in a living human subject
WO2014078623A2 (en) 2012-11-15 2014-05-22 Brandeis University Tethering cysteine residues using cyclic disulfides
EP2886107A1 (en) 2013-12-17 2015-06-24 ObsEva S.A. Oral formulations of pyrrolydine derivatives
EA037070B9 (ru) 2015-10-01 2021-03-29 Афарм С.Р.Л. Комбинация гликозаминогликанов и антацидного агента и содержащая ее композиция
IT201600101413A1 (it) 2016-10-10 2018-04-10 Sofar Swiss S A Composizione liquida per uso nel trattamento del reflusso gastroesofageo
IT201700124424A1 (it) 2017-10-31 2019-05-01 Sofar Swiss Sa Compressa da succhiare e/o sciogliere in bocca a base di acido ialuronico e condroitina solfato e loro sali
IT201700124434A1 (it) 2017-10-31 2019-05-01 Sofar Swiss Sa Compressa da succhiare e/o sciogliere in bocca a base di acido ialuronico e condroitina solfato e loro sali per uso nel trattamento di una sottopopolazione di pazienti GERD.

Also Published As

Publication number Publication date
EP3522904A1 (en) 2019-08-14
US20190262388A1 (en) 2019-08-29
HUE057257T2 (hu) 2022-05-28
US11337992B2 (en) 2022-05-24
DK3522904T3 (da) 2021-12-06
PL3522904T3 (pl) 2022-02-07
ES2900565T3 (es) 2022-03-17
WO2018069832A1 (en) 2018-04-19
IT201600101413A1 (it) 2018-04-10
EP3522904B1 (en) 2021-09-15
US20220265701A1 (en) 2022-08-25
US11690867B2 (en) 2023-07-04

Similar Documents

Publication Publication Date Title
IL247841A0 (en) Heterocyclic compounds for use in the treatment of disorders mediated by pi3k gamma
HUE057257T2 (hu) Folyékony készítmény gyomor- és nyelõcsõ reflux kezelésében történõ alkalmazásra
DK3481846T3 (da) 11-substituerede 24-hydroxysteroler til anvendelse til behandling af nmda-relaterede tilstande
PT4101454T (pt) Composições para utilização no tratamento da hipertensão
ZA202001988B (en) Liquid personal cleansing composition
HK1256164A1 (zh) 用於治療神經膠質瘤的製劑
HUE044153T2 (hu) Apilimod melanóma kezelésében történõ alkalmazásra
IL263804A (en) Wnt inhibitors for use in the treatment of fibrosis
PT3423060T (pt) Imatinib para utilização no tratamento de acidente vascular cerebral
IL251345B (en) Preparations for use in the treatment of peri-implantitis
HUE039750T2 (hu) Hidroxi-buspiron mozgászavarok kezelésére
HK1225994A1 (zh) 用於治療過敏性病症的組合物
EP3440052C0 (en) COMPOUNDS FOR USE IN THE TREATMENT OF CANCER
GB2581876B (en) Compositions for use in the treatment of endometrial disorder
HUE065202T2 (hu) Készítmény bélelváltozások kezelésében való felhasználásra
ZA202006886B (en) R-fadrozole for use in the treatment of aldostonerism
GB201513543D0 (en) Compositions for use in the treatment of diabetes
ZA201408464B (en) Composition for the use in treatment of asthma
TH182881B (th) องค์ประกอบสำหรับการใช้ในการบำบัดภาวะภูมิแพ้
ZA201404780B (en) Composition for use in treatment of diabetes